Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of SARS‐CoV‐2 infection, hospitalization, and death for COVID‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study
Corrado Zenesini, Luca Vignatelli, Laura Maria Beatrice Belotti, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 11, pp. 3205-3217
Open Access | Times Cited: 11

Showing 11 citing articles:

Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment
Jinyang Zhao, Fan Xia, Xue Jiao, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration
Asmaa Yehia, Osama A. Abulseoud
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy
Lorenzo Muccioli, Corrado Zenesini, Laura Licchetta, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 2
Open Access
SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses
Muhannad Smadi, Melina Kaburis, Youval Schnapper, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 2, pp. 348-361
Open Access | Times Cited: 14
Deciphering the molecular pathways underlying dopaminergic neuronal damage in Parkinson's disease associated with SARS-CoV-2 infection
Qiuhan Xu, Sisi Jiang, Ruiqing Kang, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108200-108200
Closed Access | Times Cited: 2
Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All?
Yulia Yu. Stroylova, Anastasiia V. Konstantinova, Viktor S. Stroylov, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 498-498
Open Access | Times Cited: 5
COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection
Salvatore Iacono, Giuseppe Schirò, Chiara Davì, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 4
Life and disease status of patients with Parkinson’s disease during and after zero-COVID in China: an online survey
Pei Huang, Yuyan Tan, Biao Chen, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access
Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain
Pilar García-Casanova, Pablo Pérez‐Martínez, Teresa Sevilla, et al.
European Journal of Neurology (2024)
Open Access
Page 1

Scroll to top